Skip to main content

Table 3 Clinical variables in 441 lung adenocarcinoma patients included in survival analysis.

From: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

Clinical variable

Categories

Number of patients

T stage

T1-2

399

 

T3-4

40

N stage

Nodes uninvolved (N0)

299

 

Nodes involved (N1-2)

139

Tumor grade

Low grade (1)

60

 

Intermediate or high grade (2-3)

374

Our classifier (MAPS)

MAPS-

229

 

MAPS+ (Expressor)

211